Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma-Reference-Cited by-同舟云学术

Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma

Published:2016-08-19 Issue:3 Volume:31 Page:602-613
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Wurster K D,Hummel F,Richter J^ORCID,Giefing M,Hartmann S,Hansmann M-L,Kreher S,Köchert K,Krappmann D,Klapper W,Hummel M,Wenzel S-S,Lenz G,Janz M,Dörken B,Siebert R,Mathas S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2016238.pdf

Reference52 articles.

1. Küppers R, Engert A, Hansmann ML . Hodgkin lymphoma. J Clin Invest 2012; 122: 3439–3447.

2. Steidl C, Connors JM, Gascoyne RD . Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment. J Clin Oncol 2011; 29: 1812–1826.

3. Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med 2015; 372: 311–319.

4. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997; 100: 2961–2969.

5. Mathas S, Hinz M, Anagnostopoulos I, Krappmann D, Lietz A, Jundt F et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J 2002; 21: 4104–4113.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the ubiquitin pathway in lymphoid malignancies;Cancer Letters;2024-07

2. Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2;2024-02-13

3. PriOmics: integration of high-throughput proteomic data with complementary omics layers using mixed graphical modeling with group priors;2023-11-14

4. Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2;2023-07-25

5. Tsc2 mutation rather than Tsc1 mutation dominantly causes a social deficit in a mouse model of tuberous sclerosis complex;Human Genomics;2023-02-02